Administrative Core

行政核心

基本信息

  • 批准号:
    10711635
  • 负责人:
  • 金额:
    $ 42.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-23 至 2028-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The Administrative Core of the Washington University/University of Oklahoma/University of New Mexico Specialized Program of Research Excellence (SPORE) Route 66 Endometrial Cancer SPORE will provide executive oversight, advocacy review, and administrative support for three projects, two cores (Biospecimens, Metabolomics, and Pathology Core and the Biostatistics and Bioinformatics Core), and the Developmental Research and Career Enhancement Programs. The Administrative Core leaders will receive advice from an Endometrial Cancer Equity Group, Patient Advocates, an Internal Advisory Board, and an External Advisory Board. The first overall objective of the Administrative Core is to provide administrative support for the Route 66 Endometrial Cancer SPORE by overseeing all SPORE components, including subcontracts and per-case payment distribution; preparing annual progress reports to the National Cancer Institute; interacting with the Grants and Contracts Office at Washington University in St. Louis and with the Program Director and Chief of the Organ Systems Branch at the National Cancer Institute; and ensuring that all research with patient participants is ethical, respectful, safe, and mindful of patients' needs. The second overall objective is to provide organizational support for the Route 66 Endometrial Cancer SPORE by coordinating weekly PI meetings, monthly Steering Committee meetings, annual meetings of the External Advisory Board, and an annual retreat/Internal Advisory Board meeting; coordinating attendance at SPORE-related National Cancer Institute meetings; coordinating an annual endometrial SPORE research retreat with other Endometrial SPORE(s); ensuring effective communication and research and administrative collaboration between relevant personnel at the three institutions; and developing and maintaining a Route 66 Endometrial Cancer SPORE website and monthly electronic newsletter. The third objective is to provide scientific management for the Route 66 Endometrial Cancer SPORE by making decisions regarding whether to continue, discontinue, or replace full projects and whether to elevate Developmental Projects to the status of full projects; assisting investigators with preparing scholarly presentations, publications, regulatory documentation, and all other paperwork generated by the SPORE; and enhancing participation of underrepresented minorities in SPORE activities, both as researchers and as participants in clinical trials. The fourth objective is to provide administrative services for the clinical trials conducted within the Route 66 Endometrial Cancer SPORE by providing support and guidance for the proposed clinical trials and using the Washington University in St. Louis Institutional Review Board for single-site review. In accomplishing these objectives, the Administrative Core will help ensure that the Route 66 Endometrial Cancer SPORE achieves its mission of reducing the burden of endometrial cancer.
项目摘要 华盛顿大学/俄克拉荷马大学/新墨西哥大学的行政核心 专业研究卓越计划(孢子)66子宫内膜癌孢子将提供 执行监督,倡导审查和对三个项目,两个核心的行政支持(Biospecimens,, 代谢组学,病理学核心以及生物统计学和生物信息学核心)以及发展 研究和职业增强计划。行政核心领导者将从 子宫内膜癌权益组,患者倡导者,内部咨询委员会和外部咨询 木板。行政核心的第一个总体目标是为路线提供行政支持 66个子宫内膜癌孢子通过监督所有孢子成分,包括分包和每盘孢子 付款分配;向国家癌症研究所准备年度进度报告;与 圣路易斯华盛顿大学的赠款和合同办公室,以及计划主任兼首席 国家癌症研究所的器官系统分支;并确保所有与患者一起研究 参与者是道德,尊重,安全和注意患者需求的。第二个整体目标是 通过协调每周PI,为66号公路子宫内膜癌孢子提供组织支持 会议,每月指导委员会会议,外部顾问委员会的年度会议以及 年度务虚会/内部顾问委员会会议;协调与孢子有关的国家癌症的出席 学院会议;与其他子宫内膜 孢子(S);确保相关之间有效的沟通和研究和行政合作 三个机构的人员;并开发和维护66号子宫内膜癌孢子 网站和每月电子通讯。第三个目标是为 66号公路子宫内膜癌孢子通过决定是继续,中断还是 取代完整的项目,以及是否将发展项目提升到完整项目的状态;协助 研究人员准备学术演讲,出版物,监管文件以及所有其他 孢子产生的文书工作;并加强人数不足的少数族裔参与孢子 作为研究人员和作为临床试验的参与者的活动。第四个目标是提供 在66号公路子宫内膜癌孢子中进行的临床试验的行政服务 为拟议的临床试验提供支持和指导,并使用圣路易斯的华盛顿大学 机构审查委员会单点审查。在实现这些目标时,行政核心将 帮助确保66号公路子宫内膜癌孢子实现了减轻负担的任务 子宫内膜癌。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David G Mutch其他文献

David G Mutch的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David G Mutch', 18)}}的其他基金

Career Enhancement Program
职业提升计划
  • 批准号:
    10711642
  • 财政年份:
    2023
  • 资助金额:
    $ 42.51万
  • 项目类别:
Project 2: Inhibiting AXL to Improve Treatment Response in Endometrial Cancer
项目2:抑制AXL以改善子宫内膜癌的治疗反应
  • 批准号:
    10711637
  • 财政年份:
    2023
  • 资助金额:
    $ 42.51万
  • 项目类别:
SPORE in Endometrial Cancer
子宫内膜癌中的孢子
  • 批准号:
    8119020
  • 财政年份:
    2009
  • 资助金额:
    $ 42.51万
  • 项目类别:

相似海外基金

Craniofacial microsomia: Accelerating Research and Education (CARE)
颅面微小症:加速研究和教育 (CARE)
  • 批准号:
    10600836
  • 财政年份:
    2020
  • 资助金额:
    $ 42.51万
  • 项目类别:
Craniofacial microsomia: Accelerating Research and Education (CARE)
颅面微小症:加速研究和教育 (CARE)
  • 批准号:
    10793329
  • 财政年份:
    2020
  • 资助金额:
    $ 42.51万
  • 项目类别:
PROTOCOL REVIEW AND MONITORING SYSTEM
方案审查和监测系统
  • 批准号:
    7529393
  • 财政年份:
    2007
  • 资助金额:
    $ 42.51万
  • 项目类别:
Supporting Transition In Vocation and Education (STRIVE)
支持职业和教育转型(STRIVE)
  • 批准号:
    7324537
  • 财政年份:
    2007
  • 资助金额:
    $ 42.51万
  • 项目类别:
Administrative/Clinical Trials Core
行政/临床试验核心
  • 批准号:
    7290718
  • 财政年份:
    2007
  • 资助金额:
    $ 42.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了